Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF-FK: Reduced Tacrolimus + MMF in Liver Transplantation
NCT00151632Phase 3Terminated
- Sponsor
- CHU Rennes
- Start
- May 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate mofetil in liver transplantation, sponsored by CHU Rennes. Primary endpoints: Onset of acute rejection and Onset of at least one complication (hypertension, renal failure, diabetes) requiring specific treatment. Started May 2003; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00151632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151632.